Single Dose CHG Pharmacokinetic Study

Summary

A single 2% topical application of ReadyPrep® CHG was applied on either the abdomen (Treatment-1) or the groin (Treatment-2) whereas Treatment-3 consisted of a control treatment where the same procedure as Treatment-1 and -2 was performed, but without the topical application of ReadyPrep® CHG. The treatments were separated by a wash-out of 7 calendar days.

Timeline

Start

2017-07-21

Primary completion

2017-08-06

Completion

2017-08-06

Drugs

Indications

No indication recorded.